Search Results - "Schmidt, Lars‐Henning"
-
1
Long‐Term Follow‐Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis
Published in The Laryngoscope (01-06-2021)“…Objectives/Hypothesis Recurrent respiratory papillomatosis (RRP) is a primarily benign disease affecting the entire respiratory tract. Treatment is challenging…”
Get full text
Journal Article -
2
NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration
Published in Oncogene (04-02-2021)“…Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide underlining the urgent need for new biomarkers and therapeutic targets for…”
Get full text
Journal Article -
3
The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth
Published in Journal of thoracic oncology (01-12-2011)“…The functions of large noncoding RNAs (ncRNAs) have remained elusive in many cases. Metastasis-Associated-in-Lung-Adenocarcinoma-Transcript-1 (MALAT-1) is an…”
Get more information
Journal Article -
4
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
Published in PloS one (27-08-2015)“…Immunotherapy can become a crucial therapeutic option to improve prognosis for lung cancer patients. First clinical trials with therapies targeting the…”
Get full text
Journal Article -
5
Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
Published in Cancers (17-05-2019)“…Lung cancer is the leading cause of cancer-related deaths worldwide. With a focus on histology, there are two major subtypes: Non-small cell lung cancer…”
Get full text
Journal Article -
6
Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancer
Published in Scientific reports (17-07-2018)“…Soluble Triggering Receptor Expressed on Myeloid Cells 1 (sTREM-1) can be found in the sera of patients with infectious, autoimmune and malignant diseases. The…”
Get full text
Journal Article -
7
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
Published in PloS one (27-10-2017)“…PSMA (prostate-specific membrane antigen) is overexpressed in prostate cancer cells and is reported to be a promising target for antibody-based radioligand…”
Get full text
Journal Article -
8
Risk Factors in HIV-1 Positive Patients on the Intensive Care Unit: A Single Center Experience from a Tertiary Care Hospital
Published in Viruses (13-05-2023)“…HIV-positive patients with acquired immunodeficiency syndrome (AIDS) often require treatment on intensive care units (ICUs). We aimed to present data from a…”
Get full text
Journal Article -
9
High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma
Published in Cancers (09-03-2022)“…Via immunohistochemistry (IHC) on tissue micro arrays (TMA) clinical and prognostic impact of p53 co-playing 5′-Nucleotidase Domain-Containing Protein 2…”
Get full text
Journal Article -
10
PD-1 targeted Immunotherapy as first-line therapy for advanced non-small-cell lung cancer patients
Published in Journal of thoracic disease (01-04-2017)Get full text
Journal Article -
11
Respiratory Muscle and Lung Function in Lung Allograft Recipients: Association with Exercise Intolerance
Published in Respiration (01-05-2020)“…In lung transplant recipients (LTRs), restrictive ventilation disorder may be present due to respiratory muscle dysfunction that may reduce exercise capacity…”
Get more information
Journal Article -
12
Potential therapeutic impact of CD13 expression in non-small cell lung cancer
Published in PloS one (12-06-2017)“…Aminopeptidase N (CD13) is a zinc-binding protease that has functional effects on both cancerogenesis and tumor angiogenesis. Since CD13 is an antigen suitable…”
Get full text
Journal Article -
13
Central airway obstruction treatment with self‐expanding covered Y‐carina nitinol stents: A single center retrospective analysis
Published in Thoracic cancer (01-04-2022)“…Background Central airway obstruction (CAO) is one of the most challenging, potentially lethal complications in malignant and benign respiratory diseases…”
Get full text
Journal Article -
14
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis
Published in Oncology letters (01-11-2014)“…Recurrent respiratory papillomatosis (RRP) is a primary benign disease, which is characterized by papillomatous growth in the respiratory tract. Malignant…”
Get full text
Journal Article -
15
Prognostic impact of CD34 and SMA in cancer‐associated fibroblasts in stage I–III NSCLC
Published in Thoracic cancer (01-01-2020)“…Background Epithelial‐to‐mesenchymal transition (EMT) is a crucial step in lung cancer pathogenesis. Among others, cancer‐associated fibroblasts (CAFs) are…”
Get full text
Journal Article -
16
Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision
Published in PloS one (12-05-2016)“…Transcatheter aortic valve implantation (TAVI) has become the treatment of choice in patients with severe aortic valve stenosis who are not eligible for…”
Get full text
Journal Article -
17
90Y‐ibritumomab‐tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single‐center experience
Published in European journal of haematology (01-10-2018)“…Background Follicular lymphoma (FL) is the most frequent indolent lymphoma subtype in adults. Maintenance therapy with rituximab is frequently applied to FL…”
Get full text
Journal Article -
18
Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience
Published in Canadian respiratory journal (27-05-2020)“…Background. Alpha-1 antitrypsin deficiency (AATD) is of importance in the pathogenesis of pulmonary emphysema, chronic obstructive pulmonary diseases (COPD),…”
Get full text
Journal Article -
19
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
Published in Translational oncology (01-12-2018)“…Aminopeptidase N (CD13) is expressed on tumor vasculature and tumor cells. It represents a candidate for targeted therapy, e.g., by truncated tissue factor…”
Get full text
Journal Article -
20
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer
Published in PloS one (09-08-2017)“…[This corrects the article DOI: 10.1371/journal.pone.0177146.]…”
Get full text
Journal Article